Abstract

Platelet function testing is essential for the diagnosis of hemostasis disorders. While there are many methods used to test platelet function for research purposes, standardization is often lacking, limiting their use in clinical practice. Light transmission aggregometry has been the gold standard for over 60 years, with inherent challenges of working with live dynamic cells in specialized laboratories with independent protocols. In recent years, standardization efforts have brought forward fully automated systems that could lead to more widespread use. Additionally, new technical approaches appear promising for the future of specialized hematology laboratories. This review presents developments in platelet function testing for clinical applications.

Highlights

  • Over the last century, platelet function testing has undergone several transformations

  • This article presents recent developments in platelet function testing, and while it is difficult to predict which approaches will translate into widespread clinical hematology laboratory use, aspects of standardization, automation, and point-of-care devices will be highlighted

  • The standard in the identification and diagnosis of primary hemostatic defects, light transmission aggregometry (LTA) continues to be time, labour- and blood sample-intensive, rendering its use limited to specialized hematology laboratories

Read more

Summary

Introduction

Platelet function testing has undergone several transformations. From the development of the Duke–Ivy bleeding time [1], to the invention of the light transmission aggregometer by Gus Born [2], to the newer high throughput advances in platelet function testing [3,4], capturing platelets in their natural ability to form aggregates in response to vascular injury remains a challenge. This article presents recent developments in platelet function testing, and while it is difficult to predict which approaches will translate into widespread clinical hematology laboratory use, aspects of standardization, automation, and point-of-care devices will be highlighted

International Guidelines for Light Transmission Aggregometry Standardization
X Not mentioned X X X X
CCnnoooonnttcXcppeerrnnoottvvrraiai333ddttiieoeooooddfffnn111666
Light Transmission Aggregometry Revisited
Results
Evaluation of Granule Defects
Multiple Electrode Aggregometry
Detection of Platelet Activation Markers by Flow Cytometry
Microfluidics and Microscopy
10. Genetic Screening of Patients with Inherited Platelet Disorders
11. Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.